February 14, 2008 - The New Mexico Institute of Mining and Technology (New Mexico Tech) and Biomoda Inc. have partnered with the New Mexico Department of Veterans Services (DVS) to conduct a $350,000 clinical study using proprietary testing technology for detection of early lung cancer in the state’s veterans.

The clinical program will be administered by New Mexico Tech, a science and engineering research university in Socorro. Biomoda, through its Albuquerque office, will conduct the first year of the program using its patented noninvasive diagnostic technology for screening of early stage lung cancer in large populations. New Mexico Tech and the New Mexico Department of Veterans Services will oversee the clinical program.

Biomoda's technology is based on an application that identifies cancerous or aberrant cells from samples of lung sputum. Cancerous cells glow red under fluorescent light and can be detected under a microscope. The technology is noninvasive and designed for cancer screening of large populations at a reasonable cost.

Biomoda’s team of experts will be dedicated to the year long clinical study. The team includes representatives from TriCore Laboratories, Averion International, and Quintiles Consulting. The Black Veterans Association of New Mexico will assist with outreach to veterans.

For more information: www.biomoda.com


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Lung Imaging

Oct. 20, 2026 — Optellum has announced that its Virtual Nodule Clinic (VNC) with Lung Cancer Prediction (LCP) AI is ...

Time October 21, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
News | Prostate Cancer

Aug. 13, 2026 — Artera has announced the enrollment of the first patient in its DIRECT-AI registry study, marking the ...

Time August 14, 2026
arrow
News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Subscribe Now